OV

Olivier van der Rest

Europe, Belgium

Description

Olivier van der Rest

Investor Profile

Olivier van der Rest has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in Belgium.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (100%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Olivier van der Rest frequently co-invest with?

New Science Ventures
North America, Connecticut, United States, Greenwich
Co-Investments: 1
TS
North America, Wisconsin, United States, Belgium
Co-Investments: 1
CL
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Vives Louvain Technology Fund
Europe, Vlaams-Brabant, Belgium, Louvain-la-neuve
Co-Investments: 1
Investsud
Europe, Luxembourg, Belgium, Marche-en-famenne
Co-Investments: 1

Which angels does Olivier van der Rest often collaborate with?

PD
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1

What are some of recent deals done by Olivier van der Rest?

Novadip Biosciences

Mont-saint-guibert, Brabant Wallon, Belgium

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

BiotechnologyHealth CareMedicalTherapeutics
Series BNov 3, 2022
Amount Raised: $23,398,518